BioAmber Gets $45M VC Investment

BioAmber has raised $45 million in venture capital.

BioAmber has raised $45 million in venture capital, Business Journal reports. The financing was led by NAXOS Capital Partners and Mitsui & Company, which participated through its Cleantech & Healthcare Investment Department, adds PR Newswire.

The round was co-led by Sofinnova Partners, Cliffton Group. The capital will help the renewable chemistry company bring its products to market and also fund construction of a production plant in North America.

Click here for the story from Business Journal.

Click here for additional coverage from PR Newswire.